Search results
Shot at success: Study quantifies vaccines' undeniable influence
Fort Wayne Journal Gazette· 1 day agoSince 1974, the World Health Organization has run an ambitious vaccination program. The goal was to provide near-universal childhood vaccinations for seven diseases. A recent study, timed to ...
AbbVie Presents New Data Supporting Leading Gastroenterology Portfolio at 2024 Digestive Disease...
WKBN 27 Youngstown· 5 days ago- AbbVie will present 15 abstracts, including three oral presentations, in Crohn's disease and ulcerative colitis reinforcing AbbVie's commitment to advancing the standards of care in inflammatory ...
More than one-half of patients with Crohn's disease treated with Lilly's mirikizumab achieved...
WTRF Wheeling· 1 day agoIn Eli Lilly and Company's (NYSE: LLY) pivotal Phase 3 VIVID-1 study, patients with moderately to severely active Crohn's disease, with or without previous biologic failure, achieved statistically ...
TB has reclaimed its place as the world’s biggest infectious killer – but are its days numbered?
Daily Telegraph· 2 days agoAs patients’ immune systems were weakened by the new disease, there was a surge in TB. HIV caused 55...
New COVID-19 FLiRT variants are now the dominant variant. Could there be a summer surge?
USA Today· 7 days agoThe Centers for Disease Control and Prevention has detected a new set of COVID-19 variants nicknamed FLiRT in wastewater surveillance, according to data from the agency. From April 28 through ...
FBI gate crash suspect granted bond — with conditions
Atlanta Journal-Constitution· 5 days agoA South Carolina man accused of breaching the gate at the FBI Atlanta offices in April was granted...
Doctors rail against proposed ban against public masking
WUNC Chapel Hill· 2 days agoCameron Wolfe, an infectious disease specialist at Duke University with a knack for making medicine and science easily understood, is just as straightforward when offering his thoughts on a ...
Celltrion USA announces two-year data for ZYMFENTRA™(infliximab-dyyb) to be presented at Digestive...
FOX 59 Indianapolis· 5 days agoCelltrion USA today announced it will present the two-year results from the extended LIBERTY studies (LIBERTY-CD and LIBERTY-UC) in adult patients with moderately to severely active Crohn's ...